Cardiff Oncology (CRDF)

FY2025 Reported With Onvansertib Phase 2b Data Review


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
February 26, 2026
Report ID: 28079
Already Registered?
Click the Get Report button to login and view the full report, with price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Register Now to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Cardiff Oncology Inc.
Cardiff Oncology Inc.
Healthcare
Biotechnology
Ticker
CRDF
Current Price
$1.99 4.19%
Market Cap
$136.0M
Price Target
Refer to Report
Volume
460.5K
52wk Range
$1.48 - $4.6
© 2018-2026 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.